Cargando…

Potential prognostic factors in progression-free survival for patients with cervical cancer

BACKGROUND: Cervical cancer continues to be one of the leading causes of cancer deaths among females in low and middle-income countries. In this study, we aimed to assess the independent prognostic value of clinical and potential prognostic factors in progression-free survival (PFS) in cervical canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hui-Hui, Meng, Wei-Yu, Li, Run-Ze, Wang, Qing-Yi, Wang, Yu-Wei, Pan, Hu-Dan, Yan, Pei-Yu, Wu, Qi-Biao, Liu, Liang, Yao, Xiao-Jun, Kang, Min, Leung, Elaine Lai-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112015/ https://www.ncbi.nlm.nih.gov/pubmed/33971846 http://dx.doi.org/10.1186/s12885-021-08243-3

Ejemplares similares

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022)

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
por: Li, Jia-Xin, et al.
Publicado: (2019)

Early lung cancer diagnostic biomarker discovery by machine learning methods
por: Xie, Ying, et al.
Publicado: (2020)

Immune checkpoints and immunotherapy in non-small cell lung cancer: Novel study progression, challenges and solutions
por: Ma, Lin-Rui, et al.
Publicado: (2021)

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma
por: Huang, Jun, et al.
Publicado: (2016)

Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer
por: Hsieh, Chen-Hsi, et al.
Publicado: (2016)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors
por: Huang, Yang-Yu, et al.
Publicado: (2022)

Prognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate
por: Lee, Jae Ho, et al.
Publicado: (2017)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
por: Guzmán‐Casta, Jordi, et al.
Publicado: (2021)

The Clinical Aspects and Prognostic Factors Concerning Survival in Patients With Recurrent Cervical Cancer After Radical Hysterectomy and Adjuvant Chemoradiotherapy
por: Zhu, Hui-Ting, et al.
Publicado: (2022)

Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
por: Wang, Jian, et al.
Publicado: (2022)

Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis
por: Kang, Shengwei, et al.
Publicado: (2022)

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival
por: Shen, Xia-Bo, et al.
Publicado: (2019)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Prognostic value of IGFBP2 in various cancers: a systematic review and meta‐analysis
por: Zhang, Biao, et al.
Publicado: (2022)

MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
por: Tang, Wei, et al.
Publicado: (2012)

Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
por: Luo, Jiaxin, et al.
Publicado: (2022)

Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Progression-Free Survival, Prognostic Factors, and Surgical Outcome of Spheno-Orbital Meningiomas
por: Masalha, Waseem, et al.
Publicado: (2021)

TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
por: von Bernuth, Amelie, et al.
Publicado: (2023)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer
por: Shen, Shu-na, et al.
Publicado: (2013)

Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients
por: Huang, Lihong, et al.
Publicado: (2016)

Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study
por: Song, Yi, et al.
Publicado: (2022)

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
por: Su, Dan, et al.
Publicado: (2012)

Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy
por: Faivre, Jean-Christophe, et al.
Publicado: (2023)

A New Method to Model and Predict Progression Free Survival Based on Tumor Growth Dynamics
por: Yu, Jiajie, et al.
Publicado: (2020)

MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer
por: Duan, Fu-Gang, et al.
Publicado: (2019)

Uterine cervical melanoma presenting with rapid progression detected by PET/CT
por: Tsai, Ya-Ju, et al.
Publicado: (2012)

The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer
por: Wang, Xiao-Jing, et al.
Publicado: (2016)

Prognostic value of hypoalbuminemia for adverse outcomes in patients with rheumatic heart disease undergoing valve replacement surgery
por: Wei, Xue-biao, et al.
Publicado: (2017)

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
por: Yang, Yao-Cheng, et al.
Publicado: (2021)

miR-20b promotes growth of non-small cell lung cancer through a positive feedback loop of the Wnt/β-catenin signaling pathway
por: Ren, Tao, et al.
Publicado: (2019)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study
por: Gao, Jie, et al.
Publicado: (2021)

Heat shock factor 1 in cancer‐associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma
por: Wang, Qiong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_is0aq34pcqj7t9nam2e0p0t0h7